UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, 2021-10, Vol.27 (10), p.1825-1835

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Annals of oncology, 2019-07, Vol.30, p.iv65-iv66

2019

Link zum Volltext

Verfügbarkeit prüfen

260 RANDOMIZED CONTROLLED TRIAL FOR PROTON BEAM RADIOTHERAPY VERSUS TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA; PRELIMINARY RESULTS

Journal of hepatology, 2013-04, Vol.58, p.S111-S111

2013

Link zum Volltext

Verfügbarkeit prüfen

SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy

Journal of hepatology, 2017, Vol.66 (1), p.S513-S514

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial

Journal of hepatology, 2017, Vol.66 (1), p.S113-S113

2017

Link zum Volltext

Verfügbarkeit prüfen

Cumene hydroperoxide induced changes in oxidation–reduction potential in fresh and frozen seminal ejaculates

Andrologia, 2018-02, Vol.50 (1), p.e12796-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

Gastroenterology (New York, N.Y. 1943), 2018-09, Vol.155 (3), p.705-718

2018

Link zum Volltext

Verfügbarkeit prüfen

51 THE SAFETY AND EFFICACY OF HIGH-DOSE PROTON BEAM RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA; A PHASE II PROSPECTIVE TRIAL

Journal of hepatology, 2010, Vol.52, p.S24-S24

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Journal of hepatology, 2020-05, Vol.72 (5), p.885-895

2020

Link zum Volltext

Verfügbarkeit prüfen

Lower gastrointestinal bleeding secondary to Dieulafoy-like lesion of the rectum

Journal of clinical gastroenterology, 2000-04, Vol.30 (3), p.328-330

2000

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans

Journal of viral hepatitis, 2007-01, Vol.14 (1), p.11-21

2007

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis

Hepatology (Baltimore, Md.), 2002-10, Vol.36 (4), p.978-985

Kayali, Z

2002

Link zum Volltext

Verfügbarkeit prüfen

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Pharmacogenomics and personalized medicine, 2014-01, Vol.7 (default), p.387-398

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis

Hepatology (Baltimore, Md.), 2002-10, Vol.36 (4), p.978-985

2002

Link zum Volltext

Verfügbarkeit prüfen

FRI-448 - Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Journal of hepatology, 2018-04, Vol.68, p.S564-S564

2018

Link zum Volltext

Verfügbarkeit prüfen

FRI-488 - Characterization of changes in lipoprotein profiles of patients with nonalcoholic steatohepatitis treated with the acetyl-CoA carboxylase inhibitor GS-0976

Journal of hepatology, 2018-04, Vol.68, p.S583-S584

2018

Link zum Volltext

Verfügbarkeit prüfen

Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Journal of hepatology, 2018-04, Vol.68, p.S564

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterization of changes in lipoprotein profiles of patients with nonalcoholic steatohepatitis treated with the acetyl-CoA carboxylase inhibitor GS-0976

Journal of hepatology, 2018-04, Vol.68, p.S583-S584

2018

Link zum Volltext

Verfügbarkeit prüfen

FRI-235 - SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy

Journal of hepatology, 2017, Vol.66 (1), p.S513-S514

2017

Link zum Volltext

Verfügbarkeit prüfen

LBP-541 - Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial

Journal of hepatology, 2017, Vol.66 (1), p.S113-S113

2017

Link zum Volltext

Verfügbarkeit prüfen

P-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Link zum Volltext

Verfügbarkeit prüfen

833TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis

Liver international, 2005-02, Vol.25 (1), p.41-48

2005

Link zum Volltext

Verfügbarkeit prüfen

Lower Gastrointestinal Bleeding Secondary to Dieulafoy-like Lesion of the Rectum

Journal of clinical gastroenterology, 2000-04, Vol.30 (3), p.328-330

2000

Link zum Volltext

Verfügbarkeit prüfen

1061 Hepatic siderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis

Hepatology (Baltimore, Md.), 2003, Vol.38, p.667-667

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(51)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

260 RANDOMIZED CONTROLLED TRIAL FOR PROTON BEAM RADIOTHERAPY VERSUS TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA; PRELIMINARY RESULTS

SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy

Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial

Cumene hydroperoxide induced changes in oxidation–reduction potential in fresh and frozen seminal ejaculates

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

51 THE SAFETY AND EFFICACY OF HIGH-DOSE PROTON BEAM RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA; A PHASE II PROSPECTIVE TRIAL

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Lower gastrointestinal bleeding secondary to Dieulafoy-like lesion of the rectum

Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans

Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis

FRI-448 - Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

FRI-488 - Characterization of changes in lipoprotein profiles of patients with nonalcoholic steatohepatitis treated with the acetyl-CoA carboxylase inhibitor GS-0976

Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Characterization of changes in lipoprotein profiles of patients with nonalcoholic steatohepatitis treated with the acetyl-CoA carboxylase inhibitor GS-0976

FRI-235 - SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy

LBP-541 - Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial

P-238Phase 3 (COSMIC-312) study of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

833TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis

Lower Gastrointestinal Bleeding Secondary to Dieulafoy-like Lesion of the Rectum

1061 Hepatic siderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis

Suchergebnisse filtern